LEXICON PHARMACEUTICALS, INC. Lessee, Operating Lease, Discount Rate
LEXICON PHARMACEUTICALS, INC. (LXRX) had Lessee, Operating Lease, Discount Rate of 0.119 Rate as of 2025-09-30, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseDiscountRate · last filed 2026-03-05
- 2019-01-01: Lessee, Operating Lease, Discount Rate 9.00%.
pure
| Period end | Lessee, Operating Lease, Discount Rate |
|---|---|
| 2019-01-01 | 9.00% 10-Q · filed 2019-11-07 |
Rate
| Period end | Lessee, Operating Lease, Discount Rate |
|---|---|
| 2025-09-30 | 0.12 Rate 10-K · filed 2026-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |